Segall Bryant & Hamill LLC acquired a new position in shares of The Procter & Gamble Company (NYSE:PG - Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The firm acquired 30,314 shares of the company's stock, valued at approximately $5,250,000.
Other hedge funds have also made changes to their positions in the company. Itau Unibanco Holding S.A. purchased a new position in Procter & Gamble during the 2nd quarter valued at about $28,000. Fairway Wealth LLC purchased a new position in Procter & Gamble during the second quarter valued at approximately $29,000. POM Investment Strategies LLC bought a new position in Procter & Gamble in the second quarter worth approximately $34,000. Quest Partners LLC purchased a new stake in Procter & Gamble during the second quarter worth $36,000. Finally, Fairfield Financial Advisors LTD bought a new stake in Procter & Gamble during the 2nd quarter valued at $44,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts recently weighed in on PG shares. Barclays downgraded Procter & Gamble from an "overweight" rating to an "equal weight" rating and set a $163.00 price objective on the stock. in a research report on Monday, September 30th. JPMorgan Chase & Co. increased their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an "overweight" rating in a research report on Thursday, September 19th. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $164.00 price target on shares of Procter & Gamble in a report on Monday, October 21st. Hsbc Global Res raised Procter & Gamble to a "strong-buy" rating in a research report on Friday, October 4th. Finally, Dbs Bank lowered Procter & Gamble from a "strong-buy" rating to a "hold" rating in a research report on Thursday, August 1st. Nine investment analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company has an average rating of "Moderate Buy" and an average target price of $178.00.
Read Our Latest Stock Report on PG
Shares of NYSE PG opened at $176.26 on Friday. The firm has a market cap of $415.10 billion, a price-to-earnings ratio of 30.39, a price-to-earnings-growth ratio of 3.69 and a beta of 0.42. The Procter & Gamble Company has a 52-week low of $142.50 and a 52-week high of $177.94. The company's 50-day simple moving average is $170.04 and its 200-day simple moving average is $168.62. The company has a quick ratio of 0.55, a current ratio of 0.75 and a debt-to-equity ratio of 0.50.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating analysts' consensus estimates of $1.90 by $0.03. The business had revenue of $21.74 billion during the quarter, compared to analysts' expectations of $21.99 billion. Procter & Gamble had a return on equity of 33.25% and a net margin of 17.07%. The business's revenue was down .6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.83 earnings per share. Equities analysts predict that The Procter & Gamble Company will post 6.94 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date was Friday, October 18th. Procter & Gamble's payout ratio is 69.48%.
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,800 shares of the firm's stock in a transaction on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares of the company's stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Jon R. Moeller sold 87,979 shares of the company's stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.40, for a total transaction of $14,991,621.60. Following the completion of the sale, the chief executive officer now directly owns 300,777 shares of the company's stock, valued at $51,252,400.80. This represents a 22.63 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 160,693 shares of company stock worth $27,311,345 over the last three months. Insiders own 0.18% of the company's stock.
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.